What Researchers Did
Researchers reported the case of a 44-year-old woman with radiation-damaged short bowel syndrome and severe hypomagnesaemia treated with hyperbaric oxygen therapy.
What They Found
Following 25 sessions of hyperbaric oxygen therapy, the patient was able to discontinue intravenous magnesium, which she had required every 5-7 days for 11 months. She maintained serum magnesium levels with oral treatment and showed improvements in weight and stoma output. For over 4 years post-therapy, she did not require further intravenous magnesium.
What This Means for Canadian Patients
This case suggests that hyperbaric oxygen therapy could be a potential treatment option for Canadian patients experiencing severe malabsorption and hypomagnesaemia due to radiation-damaged short bowel syndrome. It may help reduce the need for frequent intravenous supplementation and improve overall nutritional status.
Canadian Relevance
This study has no direct Canadian connection as it was not conducted in Canada, nor did it involve Canadian researchers or patients.
Study Limitations
A major limitation of this study is that it is a single case report, which limits the generalizability of its findings to a broader patient population.